Search

everythinglearnresearchcommunity

for

Search:↓

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

A new method was developed to accurately detect and measure 47 different drug ingredients in various products.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Combining ultrasound and microneedles improves drug delivery through the skin.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

A young man developed a rare, bilateral scalp condition after head trauma, causing hair loss but no neurological or eye issues.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Plant-based treatments can effectively and safely treat hair loss.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

No cure exists for alopecia areata, and treatments are personalized.